Savara Inc (SVRA)
Healthcare
Biotechnology
5.50 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Savara Inc (SVRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.5% of the shares are freely tradable; institutional investors hold 104.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
104.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
63.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
17.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
205Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| NEA Management Company, LLC | 11.94 | 24,471,264 | +0.0 | 03/31/2026 |
| Bain Capital Life Sciences Investors, LLC | 8.59 | 17,600,621 | +0.0 | 03/31/2026 |
| VR Adviser, LLC | 6.71 | 13,740,375 | +0.0 | 03/31/2026 |
| Deerfield Management Co | 6.62 | 13,569,000 | +0.0 | 03/31/2026 |
| TCG Crossover Management, LLC | 6.03 | 12,362,205 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.51 | 11,291,185 | +1.7 | 03/31/2026 |
| Vanguard Group Inc | 4.90 | 10,041,647 | +20.8 | 12/31/2025 |
| Frazier Life Sciences Management, L.P. | 4.74 | 9,720,852 | -1.4 | 03/31/2026 |
| Polar Capital Holdings PLC | 4.66 | 9,541,786 | +14.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Healthcare Opports Inc | 4.00 | 8,191,216 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.